Remove Clinical Pharmacology Remove Drug Development Remove Drug Trials
article thumbnail

How Improving Diversity Can Benefit Clinical Trials

Alta Sciences

Food and Drug Administration (FDA) published a draft guidance to ensure greater diversity in clinical trials, which is expected to become a final guidance by June 2025. Image Thumbnail_diversity in clinical trials_VAbutton.jpg Synopsis Representation and inclusion of various minority groups is crucial for medical research.